RT @RFRedberg: need more evidence/ less hype before new “innovative” technologies. drug-eluting stents no benefit over bare-metal.https://t…
#CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https://t.co/kopDnl4jM2
Question - how may folk care about/take note of the 'evidence qual low' statement here? How many just note 'may lead to fewer..'? https://t.co/GSGaPwjcH8
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @RFRedberg: need more evidence/ less hype before new “innovative” technologies. drug-eluting stents no benefit over bare-metal.https://t…
RT @RFRedberg: need more evidence/ less hype before new “innovative” technologies. drug-eluting stents no benefit over bare-metal.https://t…
RT @RFRedberg: need more evidence/ less hype before new “innovative” technologies. drug-eluting stents no benefit over bare-metal.https://t…
RT @angioplastyorg: No benefit of DES v BMS? Really? "evidence should be interpreted w caution...quality to be low to very low due to limit…
RT @angioplastyorg: No benefit of DES v BMS? Really? "evidence should be interpreted w caution...quality to be low to very low due to limit…
No benefit of DES v BMS? Really? "evidence should be interpreted w caution...quality to be low to very low due to limitations of incl RCTs." https://t.co/eYu56z7HB0
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
need more evidence/ less hype before new “innovative” technologies. drug-eluting stents no benefit over bare-metal.https://t.co/miNEtW9Bc0”
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @pass_paces: RT @CochraneUK: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https://t…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
DES vs BMS - reduced adverse events/ revascularization but no long-term change in mortality or major CV events. https://t.co/o24YzwXgut
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @CochraneUK: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https://t.co/EO2LZEsX4U
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
Weak data? Half the men on the planet are walking around with Drug eluting stents.🤷🏻♂️ https://t.co/aPsERVgS6j
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
RT @RichardLehman1: Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.…
Massive change to drug-eluting stents in early 2000s with no clear evidence of superiority in 2017. Amazing. https://t.co/voPb0Pdo6D
RT @CochraneUK: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https:…
#CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https://t.co/a2pbL8n37q https://t.co/IBWsKXQuVv
RT @CochraneLibrary: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low h…
RT @CochraneLibrary: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low h…
RT @CochraneLibrary: #CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low h…
#CochraneEvidence: drug-eluting stents may lead to fewer adverse events than bare-metal stents but evidence qual low https://t.co/iF1FH2kSen
Benefits and harms of drug-eluting versus bare-metal stents in people with acute coronary… https://t.co/3gqspdhrZV
CochraneLibrary: Benefits and harms of drug-eluting versus bare-metal stents in people with acute coronary syndrome https://t.co/IS1PIv5L9p https://t.co/e0s3eJBimv
Drug-eluting stents versus bare-metal stents for acute coronary syndrome. https://t.co/lTYcqlWF3O